PUBLICATIONS · 36041086
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jan 1
- First author
- Hoimes CJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- 7
- note
- Source null
- related pmid
- Source null
- relationship
- Comment in
- url
- Source null
Authors and identifiers
- name
- Hoimes CJ
- type
- Author
- name
- Flaig TW
- type
- Author
- name
- Milowsky MI
- type
- Author
- name
- Friedlander TW
- type
- Author
- name
- Bilen MA
- type
- Author
- name
- Gupta S
- type
- Author
- name
- Srinivas S
- type
- Author
- name
- Merchan JR
- type
- Author
- name
- McKay RR
- type
- Author
- name
- Petrylak DP
- type
- Author
- name
- Sasse C
- type
- Author
- name
- Moreno BH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hoimes CJ
- type
- Author
- name
- Flaig TW
- type
- Author
- name
- Milowsky MI
- type
- Author
- name
- Friedlander TW
- type
- Author
- name
- Bilen MA
- type
- Author
- name
- Gupta S
- type
- Author
- name
- Srinivas S
- type
- Author
- name
- Merchan JR
- type
- Author
- name
- McKay RR
- type
- Author
- name
- Petrylak DP
- type
- Author
- name
- Sasse C
- type
- Author
- name
- Moreno BH
- type
- Author
- bibliography ids
- nci-bib-1662902bdd41950272c4d237
- book metadata
- content sha256
- 5a00588fbc81ae4695d1c56eb727d0f0f77c15eefa44f3e7d1bc750621c079c2
- document type
- citation
- dois
- 10.1200/JCO.22.01643
- electronic publication date
- display
- 2022 Aug 30
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36041086
- immutable id
- pubmed:36041086@5a00588fbc81ae4695d1c56eb727d0f0f77c15eefa44f3e7d1bc750621c079c2
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 22-31
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- 7
- note
- Source null
- related pmid
- Source null
- relationship
- Comment in
- url
- Source null
- outcomes validated
- false
- pmid
- 36041086
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 83eb5af0d3917c397be2a2e02ba4c8abb3b3c8a6f53185995ffe4552fa45b2bc
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2023 Jan 1
- precision
- day
- year
- 2023
- publication types
- Multicenter Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.
Preserved source evidence · Not medical advice
Triangle